ENZALIEVA 160MG is an Tablets medication used for treatment purposes. It is manufactured by Allieva Pharma Private Limited.
| Brand Name | ENZALIEVA 160MG |
|---|---|
| Composition | Enzalutamide Tablets 160mg |
| Manufacturer | Allieva Pharma Private Limited |
| Dosage Form | Tablets |
| Packaging | Tablets (1x7) |
| Country of Origin | India |
Enzalutamide Tablets 160mg (Enzalutamide Tablets 160mg) is a widely used Tablets medicine manufactured by Allieva Pharma Private Limited. It is commonly prescribed for...
ENZALIEVA Enzalutamide Tablets 160mg is an advanced anticancer medicine used for the treatment of prostate cancer in adult patients. It contains Enzalutamide, a powerful androgen receptor inhibitor that helps slow down the growth and spread of prostate cancer cells. This medicine is commonly prescribed by oncologists as part of hormone therapy for patients suffering from advanced or metastatic prostate cancer.
Prostate cancer is one of the most common cancers affecting men worldwide. Cancer cells in the prostate often depend on male hormones called androgens, especially testosterone, for growth and survival. Enzalutamide works by blocking the action of these hormones, helping reduce the ability of cancer cells to grow and multiply. Due to its targeted mechanism of action, ENZALIEVA is widely used in modern oncology treatment protocols for prostate cancer management.
ENZALIEVA Enzalutamide Tablets 160mg is manufactured under strict pharmaceutical quality standards to ensure safety, effectiveness, and consistent therapeutic performance. The medicine is commonly recommended in patients with:
This anticancer medicine is usually prescribed when prostate cancer continues to progress despite reduced testosterone levels or hormonal treatment. Doctors may use ENZALIEVA alone or in combination with other therapies depending on the patient’s condition, cancer stage, and overall treatment plan.
Enzalutamide Tablets are known for helping improve disease management by delaying cancer progression and supporting overall treatment outcomes. The medicine has become an important part of prostate cancer therapy due to its effectiveness in controlling androgen receptor activity, which plays a major role in prostate cancer growth.
Patients should use this medicine strictly under the supervision of qualified healthcare professionals. Proper medical monitoring and regular health checkups are important during treatment to ensure better response and patient safety.
ENZALIEVA Enzalutamide Tablets 160mg is mainly used in the treatment and management of different stages of prostate cancer. It is an important hormone therapy medicine used in modern oncology treatment programs.
ENZALIEVA is commonly prescribed for patients whose prostate cancer has spread to other parts of the body and continues to grow despite hormone therapy or reduced testosterone levels.
Doctors may recommend Enzalutamide Tablets for patients with prostate cancer that has not spread but is still progressing despite androgen deprivation therapy.
This medicine is also used in combination treatment plans for metastatic hormone-sensitive prostate cancer to help delay disease progression.
ENZALIEVA supports advanced prostate cancer treatment by blocking androgen receptor activity and slowing cancer cell growth.
Enzalutamide Tablets are widely used as part of hormone-based oncology treatment protocols in cancer care centers and hospitals.
Enzalutamide belongs to a class of medicines known as androgen receptor inhibitors. Prostate cancer cells often rely on male hormones such as testosterone for growth.
ENZALIEVA works by:
• Blocking androgen receptors
• Preventing testosterone from stimulating cancer cells
• Slowing cancer cell growth
• Helping control disease progression
This targeted mechanism helps improve treatment management in patients with advanced prostate cancer.
Like other anticancer medicines, ENZALIEVA Enzalutamide Tablets 160mg may cause side effects in some patients. Side effects can vary depending on the patient’s health condition, treatment duration, and response to therapy.
Many patients may experience tiredness, weakness, or reduced energy levels during treatment.
Hormone therapy medicines like Enzalutamide may cause hot flashes or sudden feelings of warmth.
Some patients may develop elevated blood pressure during treatment and may require regular monitoring.
Pain in muscles, joints, or bones may occur in some individuals.
Mild to moderate headaches may occasionally occur during therapy.
Patients may sometimes feel dizzy or lightheaded after taking the medicine.
Some individuals may experience loss of appetite or reduced food intake.
Fluid retention or swelling may develop in certain cases.
Sleep disturbances or insomnia may occur during treatment.
Although less common, some serious side effects require immediate medical attention.
• Seizures
• Chest pain
• Severe allergic reactions
• Difficulty breathing
• Sudden weakness
• Severe dizziness
• Unusual bleeding
• Signs of infection
Patients should immediately consult their doctor if any severe symptoms appear during treatment.
The dosage of ENZALIEVA Enzalutamide Tablets 160mg should always be determined by a qualified healthcare professional based on the patient’s condition and treatment plan.
• Usually taken once daily
• Swallow tablets whole with water
• Can be taken with or without food
• Take the medicine at the same time every day
• Do not crush, chew, or break the tablets
• Do not stop treatment without consulting a doctor
• Follow the prescribed treatment schedule carefully
• Regular medical monitoring may be required during therapy
Doctors may adjust treatment depending on:
• Cancer stage
• Response to therapy
• Side effects
• Overall patient health
Before starting treatment, patients should inform their doctor if they have:
• Heart disease
• High blood pressure
• Liver problems
• History of seizures
• Kidney disorders
• Bone-related conditions
Patients should also discuss all ongoing medicines and supplements with their healthcare provider to avoid drug interactions.
• Store in a cool and dry place
• Protect from moisture and sunlight
• Keep out of reach of children
• Store at recommended room temperature
• Advanced prostate cancer treatment support
• High-quality pharmaceutical formulation
• Trusted oncology medicine
• Effective androgen receptor inhibitor
• Suitable for modern hormone therapy protocols
• Manufactured under strict quality standards
It is mainly used for the treatment of advanced and metastatic prostate cancer.
No, Enzalutamide is a hormone therapy medicine and androgen receptor inhibitor used in prostate cancer treatment.
The medicine helps manage and slow disease progression but treatment outcomes depend on the patient’s medical condition and cancer stage.
Patients should take the tablets exactly as prescribed by their doctor, usually once daily.
Yes, tiredness and weakness are common side effects during treatment.
Yes, doctors may recommend regular health checkups and blood pressure monitoring during treatment.
No, patients should never stop treatment without medical advice.
Yes, this medicine should always be used under the supervision of qualified healthcare professionals.